Friday, December 12, 2014

Oncogene - Table of Contents alert Volume 33 Issue 50

If you are unable to see the message below, click here to view.
Oncogene

Advertisement
100 New ChIP-grade antibodies

Diagenode focuses exclusively on epigenetics and provides the largest selection of validated antibodies with dedicated technical expertise and support. Our antibodies are the only ones on the market that are validated in-house for ChIP-seq.
Check out our newest 100 antibodies.


TABLE OF CONTENTS

Volume 33, Issue 50 (December 2014)

In this issue
Review
Original Articles
Corrigendum

Also new
AOP
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Subscribe

Review

Top

Mechanisms and consequences of constitutive NF-κB activation in B-cell lymphoid malignancies

D Nagel, M Vincendeau, A C Eitelhuber and D Krappmann

Oncogene 2014 33: 5655-5665; advance online publication, January 27, 2014; 10.1038/onc.2013.565

Abstract | Full Text

Original Articles

Top

Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotype

J L L Robinson, T E Hickey, A Y Warren, S L Vowler, T Carroll, A D Lamb, N Papoutsoglou, D E Neal, W D Tilley and J S Carroll

Oncogene 2014 33: 5666-5674; advance online publication, December 2, 2013; 10.1038/onc.2013.508

Abstract | Full Text

CDK/CK1 inhibitors roscovitine and CR8 downregulate amplified MYCN in neuroblastoma cells

C Delehouzé, K Godl, N Loaëc, C Bruyère, N Desban, N Oumata, H Galons, T I Roumeliotis, E G Giannopoulou, J Grenet, D Twitchell, J Lahti, N Mouchet, M-D Galibert, S D Garbis and L Meijer

Oncogene 2014 33: 5675-5687; advance online publication, December 9, 2013; 10.1038/onc.2013.513

Abstract | Full Text

Mechanism of human PTEN localization revealed by heterologous expression in Dictyostelium

H N Nguyen, Y Afkari, H Senoo, H Sesaki, P N Devreotes and M Iijima

Oncogene 2014 33: 5688-5696; advance online publication, December 2, 2013; 10.1038/onc.2013.507

Abstract | Full Text

Downregulation of IGFBP2 is associated with resistance to IGF1R therapy in rhabdomyosarcoma

Z Kang, Y Yu, Y J Zhu, S Davis, R Walker, P S Meltzer, L J Helman and L Cao

Oncogene 2014 33: 5697-5705; advance online publication, December 2, 2013; 10.1038/onc.2013.509

Abstract | Full Text

Conditional deletion of p53 and Rb in the renin-expressing compartment of the pancreas leads to a highly penetrant metastatic pancreatic neuroendocrine carcinoma

S T Glenn, C A Jones, S Sexton, C M LeVea, S M Caraker, G Hajduczok and K W Gross

Oncogene 2014 33: 5706-5715; advance online publication, December 2, 2013; 10.1038/onc.2013.514

Abstract | Full Text

p21Waf1/Cip1 deficiency causes multiple mitotic defects in tumor cells

N-N Kreis, M Sanhaji, M A Rieger, F Louwen and J Yuan

Oncogene 2014 33: 5716-5728; advance online publication, December 9, 2013; 10.1038/onc.2013.518

Abstract | Full Text

Contribution of an alveolar cell of origin to the high-grade malignant phenotype of pregnancy-associated breast cancer

S Haricharan, S M Hein, J Dong, M J Toneff, O H Aina, P H Rao, R D Cardiff and Y Li

Oncogene 2014 33: 5729-5739; advance online publication, December 9, 2013; 10.1038/onc.2013.521

Abstract | Full Text

Corrigendum

Top

Novel cross talk between MEK and S6K2 in FGF-2 induced proliferation of SCLC cells

O E Pardo, A Arcaro, G Salerno, T D Tetley, T Valovka, I Gout and M J Seckl

Oncogene 2014 33: 5740; 10.1038/onc.2014.369

Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Nature Publishing Group | 75 Varick Street, 9th Floor | New York | NY 10013-1917 | USA

Nature Publishing Group's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS.

© 2014 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.

nature publishing group
 

No comments: